PMD2 Concept Paper: A Medtech Roadmap: New Routes to Market Access in the UK NHS by Stevenson, A., Gildea, L.

Get full text

Histoplasma capsulatum Yeasts Are Phagocytosed Via Very Late Antigen-5, Killed, and Processed for Antigen Presentation by Human Dendritic Cells by Gildea, Lucy A, Morris, Randal E, Newman, Simon L

Get full text

MT13 Digging into the Medical Technology HTA Process in Tunisia by Mordin, M., Warttig, S., Gildea, L., Long, J., D'Souza, V., Kinderas, M., Ling, C., Hartley, L.

Get full text

MT25 What Evidence Should Medical Technology Companies Expect HTA Bodies to Review? by Mordin, M., Gildea, L., Long, J., D'Souza, V., Kinderas, M., Ling, C., Warttig, S., Hartley, L.

Get full text

MT29 Understanding How Health Technology Assessment Bodies Select Medical Technology for Review: Results of an Online Survey by Gildea, L., Mordin, M., Long, J., D'Souza, V., Kinderas, M., Warttig, S., Hartley, L., Ling, C.

Get full text

MT44 Submission Process and Requirements of Nordic Health Technology Assessment Organisations for Medical Technologies: Results of an Online Survey by Kinderås, M., Gildea, L., Mordin, M., Long, J., D'Souza, V., Ling, C., Warttig, S., Hartley, L.

Get full text

MT61 Differences and Similarities of Health Economic Evaluation for Medical Technologies By HTA Bodies by D'Souza, V., Gildea, L., Mordin, M., Long, J., Kinderas, M., Ling, C., Warttig, S., Hartley, L.

Get full text

MT43 Does Real-World Evidence Play a Role in Decision-Making by HTA Bodies for Medical Technologies? by Hartley, L., Gildea, L., Mordin, M., Long, J., D'Souza, V., Kinderas, M., Ling, C., Warttig, S.

Get full text

CO69 Evidence Gap Analysis of the Burden of Illness and Treatment of Bullous Pemphigoid by Gildea, L., Copley-Merriman, K., Arvin-Berod, C., Vande Walle, K., Verheesen, P., Stoykov, I.

Get full text

CO96 Evidence Gap Analysis of the Burden of Illness and Treatment of Thyroid Eye Disease by Gildea, L., Arvin-Berod, C.., Heyes, A., Heyerick, A., Urdaniz, E., Vainilovich, Y., Trainor, L., Densmore, D.

Get full text

MT16 What Is the Medical Technology HTA Process in Japan? by Mordin, M, Bhogal, P, Warttig, S, Gildea, L, Long, J, D'Souza, V, Kinderas, M, Ling, C, Hartley, L

Get full text

MT26 HTA Requirements for Medical Technologies in Canada by Mordin, M, Bhogal, P, Warttig, S, Gildea, L, Long, J, D'Souza, V, Kinderas, M, Ling, C, Hartley, L

Get full text

MT41 Process and Requirements for Submitting Nonpharmaceutical Medical Technologies to Health Technology Assessment Authorities by Costello, J, D'Souza, V, Gildea, L, Kinderås, M, Ling, C, Marcano Belisario, J, Warttig, S

Get full text

HTA74 HTA Processes for Medical Technologies across the World – Are All Hurdles the Same? by Mordin, M., Gildea, L., Warttig, S., Costello, J., D'Souza, V., Kinderås, M., Ling, C., Marcano Belisario, J.

Get full text

Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites by Finkelman, Fred D., Shea-Donohue, Terez, Morris, Suzanne C., Gildea, Lucy, Strait, Richard, Madden, Kathleen B., Schopf, Lisa, Urban Jr, Joseph F.

Get full text

Abstract P2-12-20: Rapid evaporative ionisation mass spectrometry towards real time intraoperative oncological margin status determination in breast conserving surgery by St John, ER, Al-Khudairi, R, Balog, J, Rossi, M, Gildea, L, Speller, A, Ramakrishnan, R, Shousha, S, Takats, Z, Leff, DR, Darzi, A

Get full text

Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen by Hulette, Ben C., Ryan, Cindy A., Gildea, Lucy A., Gerberick, G. Frank

Get full text

Dendritic cells and skin sensitization: Biological roles and uses in hazard identification by Ryan, Cindy A., Kimber, Ian, Basketter, David A., Pallardy, Marc, Gildea, Lucy A., Gerberick, G. Frank

Get full text

Human Dendritic Cell Activity against Histoplasma capsulatum Is Mediated via Phagolysosomal Fusion by Gildea, Lucy A, Ciraolo, Georgianne M, Morris, Randal E, Newman, Simon L

Get full text

Interactions of Contact Allergens with Dendritic Cells: Opportunities and Challenges for the Development of Novel Approaches to Hazard Assessment by Ryan, Cindy A., Gerberick, G. Frank, Gildea, Lucy A., Hulette, Ben C., Betts, Catherine J., Cumberbatch, Marie, Dearman, Rebecca J., Kimber, Ian

Get full text